Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Losartan therapy in patents with Marfan syndrome

Trial Profile

Losartan therapy in patents with Marfan syndrome

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 29 Nov 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Losartan (Primary)
  • Indications Aortic disorders
  • Focus Therapeutic Use
  • Acronyms COMPARE
  • Most Recent Events

    • 24 Oct 2013 New trial record
    • 02 Sep 2013 Primary endpoint 'Clinical-response-rate' has been met according to results published in the European Heart Journal.
    • 02 Sep 2013 Results published in the European Heart Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top